CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net loss	$ (11,692,928)	$ (12,855,767)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	547,796	633,328
Impairment expense		253,977
Stock based compensation expense	1,356,351	3,257,305
Amortization of debt issuance costs	1,479
Provision for bad debts	20,552	423,920
Change in operating assets and liabilities:
Accounts receivable	1,081,480	3,084,311
Inventories	105,099	(28,709)
Prepaid expenses, other current assets and deposits	(268,920)	(167,448)
Accounts payable and accrued liabilities	426,924	(610,504)
Deferred revenue	1,504,958	(1,469,597)
Net cash used in operating activities	(6,917,209)	(7,479,184)
Cash flows from investing activities:
Purchases of property and equipment	(266,008)	(145,436)
Net cash used in investing activities	(266,008)	(145,436)
Cash flows from financing activities:
Net proceeds from sale of common stock and warrants	4,233,000	6,105,127
Net proceeds from secured convertible promissory notes (including related party of $1,185,000 for the year ended September 30, 2018)	1,650,000
Net cash provided by financing activities	5,883,000	6,105,127
Net decrease in cash and cash equivalents	(1,300,217)	(1,519,493)
Cash and cash equivalents at beginning of year	2,959,781	4,479,274
Cash and cash equivalents at end of year	1,659,564	2,959,781
Supplemental Disclosures of Cash Flow Information:
Cash paid during year for interest	0	0
Cash paid during year for income taxes	0	0
Non-cash investing and financing transactions:
Debt issuance costs included in accounts payable and accrued liabilities	$ 64,848
Reclassification of deferred offering costs to additional paid in capital		$ 13,986